|
Market Closed -
Nasdaq
00:30:00 27/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.900 USD | -2.36% |
|
+0.35% | -62.44% |
| 10-08 | Swiss Market Index Retreats; Novartis Shares Decline | MT |
| 10-08 | Addex Therapeutics' Neurosterix to Advance Schizophrenia Drug to Phase 2 Trials | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| ADXN | Delayed | |
CBOE
| 0QNV | Real-time | |
Deutsche Boerse AG
| APE | Delayed | |
Börse Stuttgart
| APE | Delayed | |
Boerse Muenchen
| APE | Real-time | |
Nasdaq
| ADXN | Delayed | |
CBOE
| ADXN | Real-time | |
Deutsche Boerse AG
| APE1 | Delayed | |
Börse Stuttgart
| APE1 | Delayed | |
Boerse Muenchen
| APE1 | Real-time | |
Tradegate
| APE1 | Real-time |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ADXN Stock
- ADXN Stock
- Charts Addex Therapeutics Ltd
Select your edition
All financial news and data tailored to specific country editions

















